crizotinib,rovalpituzumab tesirine
abbvie,ideaya therapeutics,pfizer
['rova,(-approval)', 'crizotinib', 'melanoma', 'ideaya ']
#ideaya reports positive interim phase 2 clinical results for #darovasertib and #crizotinibsynthetic lethal combination in #metastatic #uvealmelanoma #esmo22 $idya 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.